SHL

SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment

Retrieved on: 
Monday, April 8, 2024
Cardiology, Telemedicine, Virtual Medicine, Defense, Military, General Health, Health, Medical Devices, Health Technology, Mojave Desert, Trauma, Telehealth, Military medicine, SHL, Fortification, Nursing, Physician, ECG

One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin’s National Training Center in the Mojave Desert amidst the challenging terrains of California’s Tiefort Mountains.

Key Points: 
  • One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin’s National Training Center in the Mojave Desert amidst the challenging terrains of California’s Tiefort Mountains.
  • PC-C4, a joint, multinational experiment hosted by the U.S. Army across multiple locations in February and March allowed military medicine to explore and integrate the latest technological innovations in a field environment.
  • SmartHeart’s inclusion in this prestigious experiment underscores the growing recognition of SHL’s portable ECG technology as a game-changer in the fast-paced and demanding field of military healthcare.
  • It addresses a crucial need in the continuum of military medical care from initial non-battle evaluation to trauma response, to advanced interventions for intensive and continual care.

NEP Sweden Launches New Remote Operation Centres, Bringing Connected Broadcast Production Solutions to Region

Retrieved on: 
Thursday, March 21, 2024
eSports, Software, Networks, Entertainment, Sports, Internet, Data Management, Technology, Other Sports, Audio, Video, Other Technology, Electronic Games, PCR, SMPTE, DIVA, Media, Travel, Carbon footprint, SHL, Life, UHD, TFC, TV4, Swedish Hockey League, Engineering, Heart, Ecosystem, KDE, OB, NEP, HD, Multimedia, NEP Group

NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.

Key Points: 
  • NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.
  • View the full release here: https://www.businesswire.com/news/home/20240321734836/en/
    NEP Sweden's Remote Operation Centre (ROC) in Stockholm features five medium-sized production control rooms (PCR) and one large PCR.
  • The powerful broadcast control and networking solution empowers production teams by making IP 2110 technology fast and intuitive.
  • “There is a growing demand for connected production solutions, and we’re responding to the needs of our broadcast partners in the region by bringing the new NEP Sweden Remote Operation Centres online, applying NEP’s deep understanding and expertise of SMPTE IP 2110 infrastructure and making this innovative and environmentally sustainable solution available to our clients,” said Per de Navarro, Chief Technology Officer, NEP Sweden.

SHL Telemedicine Receives Buy Rating with $11.00 Price Target

Retrieved on: 
Thursday, March 14, 2024
Software, Telemedicine, Virtual Medicine, Finance, Health, Health Technology, Professional Services, Technology, Apps, Applications, Research, The Wall Street Journal, Growth, Clinical professor, Mayo Clinic, Telehealth, SHL, Imperial College London, Clinical trial, Wells Fargo, FINRA, Pharmaceutical industry

SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that Litchfield Hills Research, a leading equity research firm has initiated coverage of with a 'Buy' rating and an $11.00 price target.

Key Points: 
  • SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that Litchfield Hills Research, a leading equity research firm has initiated coverage of with a 'Buy' rating and an $11.00 price target.
  • This price target represents a significant premium over the company's current share price, highlighting the firm's confidence in SHL's growth trajectory and market position.
  • The equity research report emphasizes SHL Telemedicine's innovative approach and expanding market opportunities, noting that "SHLT is a pure-play in the rapidly expanding $115B telemedicine market.
  • The $11.00 price target is based on a comprehensive analysis of the company's financial health, growth prospects, and the expanding market for telemedicine services.

Intelerad Announces Three Executive Leadership Appointments to Drive Transformative Client Experiences in 2024 and Beyond

Retrieved on: 
Tuesday, January 30, 2024
Cloud, Software, Growth, Certification, Risk management, Science, TIBCO Software, Pennsylvania State University, Allscripts, SHL, MBA, Citrix Systems, NTT, Acquisition, Education, Clarkson University, Software as a service, PHR, Purdue University, Guglielmo Marconi, Engineering, TIBCO, Organization, Management

In their new roles, they will help ensure clients experience the full value of selecting Intelerad as their medical imaging provider of choice.

Key Points: 
  • In their new roles, they will help ensure clients experience the full value of selecting Intelerad as their medical imaging provider of choice.
  • “Welcoming Pete, Vivek and Erikka signals our commitment to drive tangible results and transformative client experiences throughout 2024 and beyond.
  • Intelerad’s clients are going to feel the positive impact of having these three new veteran leaders at our organization,” Bazinsky said.
  • “We are gearing up to reshape what our client experiences look like in 2024, and we anticipate excellent outcomes and unparalleled satisfaction for our clients,” Bazinsky said.

Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24

Retrieved on: 
Thursday, February 1, 2024
Cardiology, Biotechnology, Technology, Managed Care, Other Health, Health, Health Technology, Medical Devices, Internet, Telemedicine, Virtual Medicine, Clinical Trials, Telehealth, American College, Clinical trial, Patient, Imperial College London, SHL, ECG, Acute coronary syndrome, ACC, Pharmaceutical industry

The TELE-ACS trial is a pivotal study that marks a significant milestone in telemedicine and cardiovascular care.

Key Points: 
  • The TELE-ACS trial is a pivotal study that marks a significant milestone in telemedicine and cardiovascular care.
  • Erez Nachtomy, CEO of SHL Telemedicine, commented: “We would like to congratulate the team at Imperial College London on the acceptance of the TELE-ACS trial results for presentation at ACC 24.
  • This achievement is a testament to the researchers and their rigorous effort to conduct this groundbreaking work.
  • We very much look forward to seeing the presentation at ACC 24 which will share the embargoed full trial results with the global cardiology community.”
    ACC 24 Participants are invited to add the session to their itinerary using the following link: https://www.abstractsonline.com/pp8/#!/10973/presentation/22832

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

Retrieved on: 
Tuesday, December 19, 2023
Other Health, Internet, Professional Services, Telemedicine, Virtual Medicine, Technology, Health Technology, Cardiology, Insurance, Biotechnology, Other Technology, Telecommunications, Health, Example, SHL, BMC, Telehealth

This event will feature the BARMER Teledoktor application, a pioneering solution developed by SHL for BARMER, exemplifying the two companies commitment to advancing telemedicine and digital health.

Key Points: 
  • This event will feature the BARMER Teledoktor application, a pioneering solution developed by SHL for BARMER, exemplifying the two companies commitment to advancing telemedicine and digital health.
  • Erez Nachtomy, CEO of SHL Telemedicine, shared his enthusiasm: “We are incredibly excited to participate in the BMC Congress 2024, a leading forum in the healthcare industry.
  • This event represents a significant opportunity for SHL Telemedicine to showcase our innovative solutions in digital healthcare, developed in collaboration with BARMER.
  • We believe that our joint session will highlight the immense potential and positive impact of telemedicine on patient care.”

SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US

Retrieved on: 
Monday, November 27, 2023
Cardiology, Biotechnology, Managed Care, Medical Supplies, General Health, Health, Medical Devices, Other Health, SHL, Telehealth, ECG, Risk, D2C, Multimedia, Heart, Hospital, Medical device, Medical imaging, Online shopping

SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions is pleased to announce the soft launch of the SmartHeart® membership program in the US, marking a significant step forward in at-home healthcare.

Key Points: 
  • SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions is pleased to announce the soft launch of the SmartHeart® membership program in the US, marking a significant step forward in at-home healthcare.
  • View the full release here: https://www.businesswire.com/news/home/20231126806466/en/
    The SmartHeart® membership program is designed to revolutionize home-based access to cardiac care.
  • It includes the innovative, user-friendly SmartHeart® portable 12-lead ECG device, offering round-the-clock interpretation by board-certified cardiologists and on-demand telehealth visits.
  • The SmartHeart® Membership Offers to the subscribing members:
    Portable 12-lead ECG device: The SmartHeart® ECG, a cutting-edge and user-friendly device, enables high-quality 12-lead ECG performance anytime and anywhere.

SHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets

Retrieved on: 
Thursday, November 16, 2023
SHL, Targets, Science, Patient, Science Based Targets initiative, Human rights, Instrument, Environment, Sustainable procurement, Pharmaceutical industry, Renewable energy, Ethics

SHL Medical received further independent recognition for its sustainability efforts, as the Science Based Targets initiative (SBTi) has approved the company's near-term emissions targets.

Key Points: 
  • SHL Medical received further independent recognition for its sustainability efforts, as the Science Based Targets initiative (SBTi) has approved the company's near-term emissions targets.
  • The result ranks SHL Medical in the top 8% in its industry, "manufacture of medical and dental instruments and supplies", and in the top 25% of all companies globally.
  • "Our commitment towards sustainability is deeply ingrained in every facet of our operations," says Ulrich Faessler, CEO & Chairman of SHL Medical.
  • SHL Medical commits to reducing its indirect (scope 3) greenhouse gas emissions by at least 51.6% per Mio.

SHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets

Retrieved on: 
Thursday, November 16, 2023
SHL, Targets, Science, Patient, Science Based Targets initiative, Human rights, Instrument, Environment, Sustainable procurement, Pharmaceutical industry, Renewable energy, Ethics

SHL Medical received further independent recognition for its sustainability efforts, as the Science Based Targets initiative (SBTi) has approved the company's near-term emissions targets.

Key Points: 
  • SHL Medical received further independent recognition for its sustainability efforts, as the Science Based Targets initiative (SBTi) has approved the company's near-term emissions targets.
  • The result ranks SHL Medical in the top 8% in its industry, "manufacture of medical and dental instruments and supplies", and in the top 25% of all companies globally.
  • "Our commitment towards sustainability is deeply ingrained in every facet of our operations," says Ulrich Faessler, CEO & Chairman of SHL Medical.
  • SHL Medical commits to reducing its indirect (scope 3) greenhouse gas emissions by at least 51.6% per Mio.

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits

Retrieved on: 
Monday, November 6, 2023
Health, Medical Devices, Technology, Telemedicine, Virtual Medicine, Software, Cardiology, Hardware, Direct, American College, ECG, Telehealth, Automated ECG interpretation, Physician, Mortality, Cardiovascular disease, Quality of life, Hospital, CIE, SHL, D2C, Patient, American College of Cardiology, Medical imaging

A keystone of clinical cardiology, the electrocardiogram (ECG) remains the most widely performed test.

Key Points: 
  • A keystone of clinical cardiology, the electrocardiogram (ECG) remains the most widely performed test.
  • While computer-interpreted ECG programs (CIE) aid physicians in interpreting ECGs, they cannot replace the critical analysis provided by seasoned physicians.
  • In establishing a US Nationwide Cardiology Network, SHL has collaborated with HeartNexus, a team of nationally recognized, board-certified cardiologists specializing in cardiac test interpretation, peer-to-peer consultations, and on-demand patient telemedicine visits.
  • The ongoing developments embody SHL Telemedicine’s relentless pursuit of delivering unparalleled value to its customers and stakeholders while championing the transformative power of telemedicine.